EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,734,700 | -30.1% | 110,000 | -13.8% | 0.00% | -33.3% |
| Q2 2023 | $2,480,136 | -0.6% | 127,579 | +45.1% | 0.00% | 0.0% |
| Q1 2023 | $2,494,971 | +55.4% | 87,944 | +60.1% | 0.00% | +50.0% |
| Q4 2022 | $1,605,224 | +12.8% | 54,917 | +1.9% | 0.00% | 0.0% |
| Q3 2022 | $1,423,000 | -67.3% | 53,894 | -44.9% | 0.00% | -60.0% |
| Q2 2022 | $4,348,000 | -24.1% | 97,864 | -15.4% | 0.01% | 0.0% |
| Q1 2022 | $5,725,000 | +23.9% | 115,677 | +27.5% | 0.01% | +25.0% |
| Q4 2021 | $4,619,000 | -10.1% | 90,699 | -1.5% | 0.00% | -20.0% |
| Q3 2021 | $5,138,000 | -3.9% | 92,103 | -26.3% | 0.01% | 0.0% |
| Q2 2021 | $5,349,000 | +18.5% | 124,968 | +15.5% | 0.01% | +25.0% |
| Q1 2021 | $4,514,000 | +64.3% | 108,161 | +83.4% | 0.00% | +100.0% |
| Q4 2020 | $2,747,000 | +114.6% | 58,987 | +95.8% | 0.00% | +100.0% |
| Q3 2020 | $1,280,000 | -62.0% | 30,126 | -57.1% | 0.00% | -75.0% |
| Q2 2020 | $3,370,000 | -2.9% | 70,239 | -6.9% | 0.00% | -20.0% |
| Q1 2020 | $3,471,000 | -19.1% | 75,444 | +5.7% | 0.01% | 0.0% |
| Q4 2019 | $4,289,000 | -13.6% | 71,392 | -18.7% | 0.01% | -16.7% |
| Q3 2019 | $4,965,000 | -24.3% | 87,776 | -25.5% | 0.01% | -25.0% |
| Q2 2019 | $6,557,000 | -35.7% | 117,760 | -41.7% | 0.01% | -38.5% |
| Q1 2019 | $10,195,000 | -11.3% | 201,907 | -29.2% | 0.01% | -18.8% |
| Q4 2018 | $11,495,000 | +28.7% | 285,318 | +121.5% | 0.02% | +45.5% |
| Q3 2018 | $8,931,000 | +46.7% | 128,819 | +60.1% | 0.01% | +37.5% |
| Q2 2018 | $6,089,000 | +35.1% | 80,475 | -5.9% | 0.01% | +14.3% |
| Q1 2018 | $4,508,000 | +55.1% | 85,562 | +57.2% | 0.01% | +75.0% |
| Q4 2017 | $2,907,000 | +347.2% | 54,428 | +594.0% | 0.00% | +300.0% |
| Q1 2017 | $650,000 | +205.2% | 7,843 | +42.6% | 0.00% | – |
| Q2 2016 | $213,000 | -76.4% | 5,500 | -46.1% | 0.00% | -100.0% |
| Q4 2015 | $904,000 | -69.5% | 10,200 | -74.5% | 0.00% | -75.0% |
| Q3 2015 | $2,961,000 | +109.6% | 40,000 | +129.0% | 0.00% | +100.0% |
| Q2 2015 | $1,413,000 | +11.6% | 17,465 | -42.2% | 0.00% | 0.0% |
| Q1 2015 | $1,266,000 | +198.6% | 30,220 | +10.4% | 0.00% | +100.0% |
| Q4 2014 | $424,000 | -5.1% | 27,378 | -22.6% | 0.00% | 0.0% |
| Q3 2014 | $447,000 | – | 35,374 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |